[4-[[(4R)-8-fluoro-3,4-dihydro-2H-chromen-4-yl]amino]-2-pyrazolo[1,5-a]pyrazin-3-ylpyrimidin-5-yl]-oxidoazanium

C19H16FN7O2 — CID 140604836

IUPAC[4-[[(4R)-8-fluoro-3,4-dihydro-2H-chromen-4-yl]amino]-2-pyrazolo[1,5-a]pyrazin-3-ylpyrimidin-5-yl]-oxidoazanium
SMILES[O-][NH2+]c1cnc(-c2cnn3ccncc23)nc1N[C@@H]1CCOc2c(F)cccc21
InChIInChI=1S/C19H16FN7O2/c20-13-3-1-2-11-14(4-7-29-17(11)13)24-19-15(26-28)9-22-18(25-19)12-8-23-27-6-5-21-10-16(12)27/h1-3,5-6,8-10,14H,4,7,26H2,(H,22,24,25)/t14-/m1/s1
InChIKeyPYWAZOPCXPCTOU-CQSZACIVSA-N
MW393.38 g/mol
LogP1.95
Rot. Bonds4

About [4-[[(4R)-8-fluoro-3,4-dihydro-2H-chromen-4-yl]amino]-2-pyrazolo[1,5-a]pyrazin-3-ylpyrimidin-5-yl]-oxidoazanium

[4-[[(4R)-8-fluoro-3,4-dihydro-2H-chromen-4-yl]amino]-2-pyrazolo[1,5-a]pyrazin-3-ylpyrimidin-5-yl]-oxidoazanium (PubChem CID 140604836) has the molecular formula C19H16FN7O2 and a molecular weight of 393.38 g/mol. Its IUPAC name is [4-[[(4R)-8-fluoro-3,4-dihydro-2H-chromen-4-yl]amino]-2-pyrazolo[1,5-a]pyrazin-3-ylpyrimidin-5-yl]-oxidoazanium.

Molecular Properties

Compound Name[4-[[(4R)-8-fluoro-3,4-dihydro-2H-chromen-4-yl]amino]-2-pyrazolo[1,5-a]pyrazin-3-ylpyrimidin-5-yl]-oxidoazanium
PubChem CID140604836
Molecular FormulaC19H16FN7O2
Molecular Weight393.38 g/mol
Exact Mass393.13
IUPAC Name[4-[[(4R)-8-fluoro-3,4-dihydro-2H-chromen-4-yl]amino]-2-pyrazolo[1,5-a]pyrazin-3-ylpyrimidin-5-yl]-oxidoazanium
SMILES[O-][NH2+]c1cnc(-c2cnn3ccncc23)nc1N[C@@H]1CCOc2c(F)cccc21
InChIInChI=1S/C19H16FN7O2/c20-13-3-1-2-11-14(4-7-29-17(11)13)24-19-15(26-28)9-22-18(25-19)12-8-23-27-6-5-21-10-16(12)27/h1-3,5-6,8-10,14H,4,7,26H2,(H,22,24,25)/t14-/m1/s1
InChIKeyPYWAZOPCXPCTOU-CQSZACIVSA-N
XLogP1.95
TPSA116.90 Ų
H-Bond Donors2
H-Bond Acceptors8
Rotatable Bonds4
Heavy Atoms29
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500393.38
LogP ≤ 51.95
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 108

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}

Analyze [4-[[(4R)-8-fluoro-3,4-dihydro-2H-chromen-4-yl]amino]-2-pyrazolo[1,5-a]pyrazin-3-ylpyrimidin-5-yl]-oxidoazanium with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of [4-[[(4R)-8-fluoro-3,4-dihydro-2H-chromen-4-yl]amino]-2-pyrazolo[1,5-a]pyrazin-3-ylpyrimidin-5-yl]-oxidoazanium?
The IUPAC name of [4-[[(4R)-8-fluoro-3,4-dihydro-2H-chromen-4-yl]amino]-2-pyrazolo[1,5-a]pyrazin-3-ylpyrimidin-5-yl]-oxidoazanium (CID 140604836) is [4-[[(4R)-8-fluoro-3,4-dihydro-2H-chromen-4-yl]amino]-2-pyrazolo[1,5-a]pyrazin-3-ylpyrimidin-5-yl]-oxidoazanium.
What is the SMILES notation for [4-[[(4R)-8-fluoro-3,4-dihydro-2H-chromen-4-yl]amino]-2-pyrazolo[1,5-a]pyrazin-3-ylpyrimidin-5-yl]-oxidoazanium?
The canonical SMILES for [4-[[(4R)-8-fluoro-3,4-dihydro-2H-chromen-4-yl]amino]-2-pyrazolo[1,5-a]pyrazin-3-ylpyrimidin-5-yl]-oxidoazanium is [O-][NH2+]c1cnc(-c2cnn3ccncc23)nc1N[C@@H]1CCOc2c(F)cccc21.
What is the InChIKey of [4-[[(4R)-8-fluoro-3,4-dihydro-2H-chromen-4-yl]amino]-2-pyrazolo[1,5-a]pyrazin-3-ylpyrimidin-5-yl]-oxidoazanium?
The InChIKey is PYWAZOPCXPCTOU-CQSZACIVSA-N. The full InChI is InChI=1S/C19H16FN7O2/c20-13-3-1-2-11-14(4-7-29-17(11)13)24-19-15(26-28)9-22-18(25-19)12-8-23-27-6-5-21-10-16(12)27/h1-3,5-6,8-10,14H,4,7,26H2,(H,22,24,25)/t14-/m1/s1.
What are the key properties of [4-[[(4R)-8-fluoro-3,4-dihydro-2H-chromen-4-yl]amino]-2-pyrazolo[1,5-a]pyrazin-3-ylpyrimidin-5-yl]-oxidoazanium?
[4-[[(4R)-8-fluoro-3,4-dihydro-2H-chromen-4-yl]amino]-2-pyrazolo[1,5-a]pyrazin-3-ylpyrimidin-5-yl]-oxidoazanium has a molecular weight of 393.38 g/mol, XLogP of 1.95, 4 rotatable bonds, 2 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for [4-[[(4R)-8-fluoro-3,4-dihydro-2H-chromen-4-yl]amino]-2-pyrazolo[1,5-a]pyrazin-3-ylpyrimidin-5-yl]-oxidoazanium is sourced from PubChem (CID 140604836), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).